• Publications
  • Influence
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
TLDR
A comprehensive handbook on the most relevant aspects for the assessments of spondyloarthritis, covering classification criteria, MRI and x rays for sacroiliac joints and the spine, a complete set of all measurements relevant for clinical trials and international recommendations for the management of SpA are provided.
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
TLDR
The new ASAS classification criteria for axial SpA can reliably classify patients for clinical studies and may help rheumatologists in clinical practice in diagnosing axial spondyloarthritis in those with chronic back pain.
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.
TLDR
With a calculated prevalence of 1.9%, spondylarthropathies are among the most frequent rheumatic diseases in the white population and HLA-B27 positive persons carry a 20-fold increased risk of developing SpA.
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group
TLDR
For the first time, MRI findings relevant for sacroiliitis have been defined by consensus by a group of rheumatologists and radiologists to help in applying correctly the imaging feature “active sacroiliaitis by MRI” in the new ASAS classification criteria for axial SpA.
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including
TLDR
The ASAS group has developed candidate criteria for the classification of axial SpA that include patients without radiographic sacroiliitis, and the candidate criteria need to be validated in an independent international study.
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
TLDR
The 2016 Assessment of SpondyloArthritis international Society-EULAR recommendations provide up-to-date guidance on the management of patients with axSpA and three overarching principles and 13 recommendations deal with surgery and spinal fractures.
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
TLDR
The new ASAS classification criteria for peripheral SpA performed well in patients presenting with peripheral arthritis, enthesitis and/or dactylitis, particularly regarding sensitivity.
How to diagnose axial spondyloarthritis early.
TLDR
This approach can help clinicians to diagnose with a high degree of confidence axial SpA at an early stage in patients with IBP who lack radiographic sacroiliitis.
Ankylosing spondylitis: an overview
TLDR
Emerging biological therapies target the inflammatory processes underlying AS, and thus, may favourably alter the disease process, in addition to providing symptom relief.
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
TLDR
CZP rapidly reduced the signs and symptoms of axSpA, with no new safety signals observed compared to the safety profile of CZP in RA, and similar improvements were observed across C ZP dosing regimens, and in AS and nr-axSpA patients.
...
1
2
3
4
5
...